Investigating how tau protein spreads in Alzheimer's disease

Heparan Sulfate 3-O-Sulfation in Transcellular Propagation of Tauopathy in Alzheimer's Disease

NIH-funded research Rensselaer Polytechnic Institute · NIH-10875754

This study is looking at how a protein called tau, which forms tangles in the brains of people with Alzheimer's, affects thinking and memory, and aims to find new treatments that could help slow down the disease.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionRensselaer Polytechnic Institute NIH-funded
Lab location1 site (Troy, United States)
Project IDNIH-10875754 on NIH RePORTER

What this research studies

This research focuses on understanding how neurofibrillary tangles, which are made of tau protein, contribute to cognitive decline in Alzheimer's disease. The team will explore the interactions between tau and specific molecules on the surface of neurons, aiming to uncover the structural details of these interactions. By studying these processes at molecular, cellular, and organismal levels, the researchers hope to identify potential drugs that can disrupt tau propagation and modify the course of the disease.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals diagnosed with Alzheimer's disease or those at risk of developing it.

Not a fit: Patients with other forms of dementia unrelated to tau pathology may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that slow down or alter the progression of Alzheimer's disease.

How similar studies have performed: Previous research has shown promise in targeting tau interactions, indicating that this approach could lead to significant advancements in Alzheimer's treatment.

Where this research is happening

Troy, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementiaAlzheimer syndromeAlzheimer's DiseaseAlzheimer's disease brainAlzheimer's disease therapy
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.